Diag Capital Management, LP 13F 持仓 · 最近申报 2018年Q4
Diag Capital Management 在 2018年Q4（报告期截至 2018-12-31）的 SEC 13F 申报中报告了 40 只证券，申报市值合计 8,743.40 万美元。前几大持仓：BAX（6.47%）、ATNXQ（6.23%）、ZBH（5.66%）。本季前 25 大持仓中：新建仓 25 只。
| 排名 | 代码 | 公司 | 市值 | 占组合 | 股数 | 变动 |
|---|---|---|---|---|---|---|
| 1 | BAX | BAXTER INTL INC | $5.7M | 6.47% | 85,933 | 新建仓 |
| 2 | ATNXQ | ATHENEX INC | $5.4M | 6.23% | 429,046 | 新建仓 |
| 3 | ZBH | ZIMMER BIOMET HLDGS INC | $4.9M | 5.66% | 47,684 | 新建仓 |
| 4 | ABBV | ABBVIE INC | $4.6M | 5.32% | 50,420 | 新建仓 |
| 5 | INCY | INCYTE CORP | $4.6M | 5.25% | 72,196 | 新建仓 |
| 6 | QTRX | QUANTERIX CORP | $4.1M | 4.69% | 223,949 | 新建仓 |
| 7 | CELG | CELGENE CORP | $4.0M | 4.63% | 63,159 | 新建仓 |
| 8 | AMGN | AMGEN INC | $3.9M | 4.48% | 20,110 | 新建仓 |
| 9 | MDT | MEDTRONIC PLC | $3.3M | 3.76% | 36,180 | 新建仓 |
| 10 | QTNT | QUOTIENT LTD | $3.2M | 3.69% | 526,932 | 新建仓 |
| 11 | PCRX | PACIRA PHARMACEUTICALS INC | $3.2M | 3.67% | 74,502 | 新建仓 |
| 12 | TAK | TAKEDA PHARMACEUTICAL CO LTD | $3.0M | 3.41% | 177,260 | 新建仓 |
| 13 | ABT | ABBOTT LABS | $2.8M | 3.19% | 38,585 | 新建仓 |
| 14 | ZLAB | ZAI LAB LTD | $2.8M | 3.19% | 120,092 | 新建仓 |
| 15 | VTRS | MYLAN N V | $2.7M | 3.12% | 99,410 | 新建仓 |
| 16 | PTEIQ | POLARITYTE INC | $2.5M | 2.82% | 182,833 | 新建仓 |
| 17 | VRAYQ | VIEWRAY INC | $2.4M | 2.76% | 397,375 | 新建仓 |
| 18 | REGN | REGENERON PHARMACEUTICALS | $2.2M | 2.47% | 5,792 | 新建仓 |
| 19 | AKRXQ | AKORN INC | $2.1M | 2.46% | 634,046 | 新建仓 |
| 20 | TEVA | TEVA PHARMACEUTICAL INDS LTD | $2.2M | 2.46% | 139,531 | 新建仓 |
| 21 | HAE | HAEMONETICS CORP | $2.1M | 2.43% | 21,220 | 新建仓 |
| 22 | ARGX | ARGENX SE | $1.6M | 1.84% | 16,712 | 新建仓 |
| 23 | BHVN1 | BIOHAVEN PHARMACTL HLDG CO L | $1.4M | 1.62% | 38,319 | 新建仓 |
| 24 | MMSI | MERIT MED SYS INC | $1.4M | 1.60% | 25,092 | 新建仓 |
| 25 | GWPH | GW PHARMACEUTICALS PLC | $1.3M | 1.50% | 13,460 | 新建仓 |
来源：SEC 13F 申报文件 · 截至 2018-12-31
本期 13F-HR 中的全部持仓，以及相对上季度的变化。
13F 持仓，最新季度
来源SEC EDGAR13F-HR